| Unique ID issued by UMIN | UMIN000063710 |
|---|---|
| Receipt number | R000072900 |
| Scientific Title | A Multicenter, Open-Label, Randomized Controlled Trial of Recombinant Thrombomodulin Monotherapy versus Antithrombin and Recombinant Thrombomodulin Combination Therapy for Sepsis-Induced Disseminated Intravascular Coagulation |
| Date of disclosure of the study information | 2026/11/20 |
| Last modified on | 2026/11/20 16:02:33 |
Randomized Controlled Trial of rTM Monotherapy vs. AT+rTM Combination Therapy for Sepsis-Induced DIC
The STARLET (Sepsis Therapy with Antithrombin and Recombinant LE Thrombomodulin) trial
A Multicenter, Open-Label, Randomized Controlled Trial of Recombinant Thrombomodulin Monotherapy versus Antithrombin and Recombinant Thrombomodulin Combination Therapy for Sepsis-Induced Disseminated Intravascular Coagulation
The STARLET (Sepsis Therapy with Antithrombin and Recombinant LE Thrombomodulin) trial
| Japan |
Sepsis-induced disseminated intravascular coagulation (Sepsis-induced DIC)
| Anesthesiology | Emergency medicine | Intensive care medicine |
Others
NO
To scientifically evaluate the efficacy (improvement in DIC resolution rate on Day 3, etc.) and safety (hemorrhagic adverse events, etc.) of combination therapy with recombinant thrombomodulin (rTM) and antithrombin (AT) compared with rTM monotherapy in adult patients with sepsis-induced DIC and AT activity <= 70% in a multicenter randomized controlled trial.
Efficacy
DIC resolution rate on Day 3 after treatment initiation
28-day and 90-day mortality
Improvement in organ dysfunction (change in SOFA score)
ICU-free days Hemorrhagic adverse events (classified according to ISTH bleeding criteria)
Changes in biomarkers (DAMPs: Histone, HMGB-1, syndecan-1, cf-DNA, etc.; at participating DAMPs-measurement sites only)
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
YES
NO
Institution is considered as a block.
YES
Central registration
2
Treatment
| Medicine |
In addition to standard therapy, intravenous administration of recombinant thrombomodulin (rTM) at 380 U/kg (0.06 mg/kg)/day (once daily over 30 minutes, without dose reduction for renal dysfunction) for 6 days and antithrombin (AT) at 50 IU/kg/day for 5 days.
In addition to standard therapy, intravenous administration of recombinant thrombomodulin (rTM) at 380 U/kg (0.06 mg/kg)/day (once daily over 30 minutes, without dose reduction for renal dysfunction) for 6 days.
| 18 | years-old | <= |
| Not applicable |
Male and Female
Aged 18 years or older at enrollment.
Diagnosed with sepsis meeting the Sepsis-3 definition.
Acute DIC diagnostic criteria (JAAM2-DIC score) >= 3.
Antithrombin (AT) activity <= 70%.
Written informed consent obtained from the patient or legally authorized representative.
Underlying hematological malignancy such as leukemia or myelodysplastic syndrome.
Expected survival of less than 24 hours at the time of enrollment as judged by the attending physician.
Severe hepatic dysfunction (e.g., Child-Pugh class C).
Active bleeding or extremely high risk of bleeding.
Pregnant or breastfeeding.
70
| 1st name | Takaaki |
| Middle name | |
| Last name | Totoki |
Osaka Medical and Pharmaceutical University
Department of Anesthesiology
5698686
2-7 Daigakumachi, Takatsuki, Osaka
84035329
ttktkak@gmail.com
| 1st name | TAKAAKI |
| Middle name | |
| Last name | TOTOKI |
Osaka Medical and Pharmaceutical University
Department of Anesthesiology
5690804
2-7 Daigakumachi, Takatsuki, Osaka
84035329
takaaki.totoki@ompu.ac.jp
Osaka Medical and Pharmaceutical University
Osaka Medical and Pharmaceutical University
Other
Osaka Medical and Pharmaceutical University
2-7 Daigakumachi, Takatsuki, Osaka 569-8686, Japan
072-683-1221
takaaki.totoki@ompu.ac.jp
NO
| 2026 | Year | 11 | Month | 20 | Day |
Unpublished
Preinitiation
| 2026 | Year | 11 | Month | 20 | Day |
| 2026 | Year | 12 | Month | 01 | Day |
| 2028 | Year | 03 | Month | 31 | Day |
| 2026 | Year | 11 | Month | 20 | Day |
| 2026 | Year | 11 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072900